Actinium Pharmaceuticals announces commencement of rights offering subscription period
Actinium announced the subscription period for its rights offering has commenced. The broker, dealer, bank or other nominee may establish a deadline before March 2, 2018, by which instructions to exercise subscription rights, along with the required subscription payment, must be received. February 22, 2018